Articles tagged "Risk factors"

2019 American Transplant Congress
Recipient and Donor Factors at the Time of Transplant as Predictors of Graft Outcomes
K. Soliman¹, V. Rohan², S. Zemin¹, A. Price¹, A. P. Salas¹, D. Lazarus¹, M. Casey³, D. J. Taber², V. Rao³
¹Medicine, Medical University of South Carolina, Charleston, SC, ²Surgery, Medical University of South Carolina, Charleston, SC, ³Medicine and Surgery, Medical University of South Carolina, Charleston, SC
*Purpose: As the ESRD population ages and the impetus to increase utilization of donor organs grows, we aimed to evaluate the impact of donor and…
2019 American Transplant Congress
The C-Statistic Provides No Information on the Accuracy of Program Evaluations or the Presence of Unmeasured Confounders
A. Wey, N. Salkowski, B. Kasiske, M. Skeans, S. Gustafson, A. Israni, J. Snyder
SRTR, Minneapolis, MN
*Purpose: The C-statistic of risk-adjustment models is regularly used to assess accuracy of program evaluations or determine presence of unmeasured confounding. However, the C-statistic depends…
2019 American Transplant Congress
Lower Extremity Impairment and Frailty among Adults with Diabetes Awaiting Kidney Transplantation
E. Lorenz, A. Kukla, C. Kennedy, R. McCoy, L. Hickson
Mayo Clinic, Rochester, MN
*Purpose: Frailty and lower extremity impairment, both indicators of poor physical performance, are predictive of all-cause mortality among patients awaiting kidney transplantation (KT). Diabetes, the…
2019 American Transplant Congress
Elevated Visceral Adiposity is Associated with Post-Liver Transplant Mortality and Poorly Correlates with BMI in a Prospective Cohort Study
R. Sharma, R. Rosenblatt, R. Knotts, J. Pisa, E. Verna
Division of Liver Diseases and Transplantation, Columbia Univerisity Medical Center, New York, NY
*Purpose: Obesity is increasingly common in end-stage-liver disease (ESLD). While obesity adversely affects outcomes, whether abnormalities in specific adipose tissue (AT) compartments lead to increased…
2019 American Transplant Congress
Metabolomic Study Of Sarcopenia In Patients Prior To Liver Transplantation
S. Ries,¹, N. J. Skill¹, E. Campbell¹, R. Daniel², C. A. Kubal¹, M. S. Richard¹, M. A. Maluccio¹
¹Surgery, Indiana University, Indianapolis, IN, ²University of Washington, Seattle, WA
*Purpose: Sarcopenia is defined as the loss of muscle mass, typically associated with aging, but frequently appearing in liver disease patients. In particular, sarcopenia present…
2019 American Transplant Congress
The Role of Recipient Weight in Renal Transplantation Revisited; Not Quite the Obesity Paradox
A. Asderakis, R. Tahawar, T. Sabah, U. Khalid, M. Stephens
Cardiff Transplant Unit, University Hospital of Wales, Cardiff, United Kingdom
*Purpose: Studies conflict whether obesity is associated with higher risk of failure and death among kidney transplant recipients. ESRF patients show the obesity paradox where…
2019 American Transplant Congress
Developing a Patient Specific Search: Feedback from Kidney Transplant Candidates and Recipients
W. T. McKinney¹, M. J. Bruin², C. R. Schaffhausen¹, S. Chu², J. Snyder³, A. Matas⁴, B. Kasiske⁵, A. K. Israni¹
¹Nephrology, Hennepin Healthcare Research Institute, Minneapolis, MN, ²College of Design, University of Minnesota, St. Paul, MN, ³Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN, ⁴Department of Surgery, University of Minnesota, Minneapolis, MN, ⁵Department of Medicine, Hennepin Healthcare, Minneapolis, MN
*Purpose: Patients in need of kidney transplantation face numerous obstacles when identifying a transplant center for treatment. Acceptance criteria, waiting time, and post-transplant allograft survival…
2019 American Transplant Congress
Risk Stratification of Cytomegalovirus Seropositive Kidney Transplant Recipients for CMV Infection
M. M. Azar¹, A. Baghban¹, K. Belfield¹, R. Assi², M. Malinis¹
¹Yale University, New Haven, CT, ²University of Pennsylvania, Philadelphia, PA
*Purpose: Current consensus guidelines for CMV prevention recommend valganciclovir (VGCV) prophylaxis for 3 months after transplantation for CMV R+ kidney transplant recipients (KTR). This standard…
2019 American Transplant Congress
Consideration for Offering Hepatitis C Antibody Positive Donor Grafts to All Patients Listed for Transplant
L. Smith
Vanderbilt Transplant Center, Nashville, TN
*Purpose: Background: The field of organ transplantation continuously struggles with inadequate numbers of donor organs. Therefore, efforts remain focused on increasing organ utilization and expanding…
2019 American Transplant Congress
Paradoxical Differential Post-transplant Rates Of Change Of Serum Proteins In Pediatric Liver Patients With Evidence For A Novel Sarcopenic-dependent Serum Protein Stimulating Factor
C. M. Schmidt¹, J. Molleston², G. S. Rao², C. A. Kubal¹, S. Atoa¹, R. S. Mangus¹
¹Surgery, Transplant Division, Indiana University, Indianapolis, IN, ²Pediatrics, Division of GI and Hepatology, Indiana University, Indianapolis, IN
*Purpose: Pediatric patients with liver disease suffer from hypoalbuminemia, sarcopenia, and malnutrition. This study aims to quantify differential rates of change (ROC) and post-TX normalization…